{"title":"配位化学表明,独立观察到的二甲双胍和 Zn2+ 对 COVID-19 的益处并不是独立的","authors":"Thomas D. Lockwood","doi":"10.1007/s10534-024-00590-5","DOIUrl":null,"url":null,"abstract":"<div><p>Independent trials indicate that either oral Zn<sup>2+</sup> or metformin can separately improve COVID-19 outcomes by approximately 40%. Coordination chemistry predicts a mechanistic relationship and therapeutic synergy. Zn<sup>2+</sup> deficit is a known risk factor for both COVID-19 and non-infectious inflammation. Most dietary Zn<sup>2+</sup> is not absorbed. Metformin is a naked ligand that presumably increases intestinal Zn<sup>2+</sup> bioavailability and active absorption by cation transporters known to transport metformin. Intracellular Zn<sup>2+</sup> provides a natural buffer of many protease reactions; the variable “set point” is determined by Zn<sup>2+</sup> regulation or availability. A Zn<sup>2+</sup>-interactive protease network is suggested here. The two viral cysteine proteases are therapeutic targets against COVID-19. Viral and many host proteases are submaximally inhibited by exchangeable cell Zn<sup>2+</sup>. Inhibition of cysteine proteases can improve COVID-19 outcomes and non-infectious inflammation. Metformin reportedly enhances the natural moderating effect of Zn<sup>2+</sup> on bioassayed proteome degradation. Firstly, the dissociable metformin–Zn<sup>2+</sup> complex could be actively transported by intestinal cation transporters; thereby creating artificial pathways of absorption and increased body Zn<sup>2+</sup> content. Secondly, metformin Zn<sup>2+</sup> coordination can create a non-natural protease inhibitor independent of cell Zn<sup>2+</sup> content. Moderation of peptidolytic reactions by either or both mechanisms could slow (a) viral multiplication (b) viral invasion and (c) the pathogenic host inflammatory response. These combined actions could allow development of acquired immunity to clear the infection before life-threatening inflammation. Nirmatrelvir (Paxlovid®) opposes COVID-19 by selective inhibition the viral main protease by a Zn<sup>2+</sup>-independent mechanism. Pending safety evaluation, predictable synergistic benefits of metformin and Zn<sup>2+</sup>, and perhaps metformin/Zn<sup>2+</sup>/Paxlovid® co-administration should be investigated.</p></div>","PeriodicalId":491,"journal":{"name":"Biometals","volume":"37 4","pages":"983 - 1022"},"PeriodicalIF":4.1000,"publicationDate":"2024-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s10534-024-00590-5.pdf","citationCount":"0","resultStr":"{\"title\":\"Coordination chemistry suggests that independently observed benefits of metformin and Zn2+ against COVID-19 are not independent\",\"authors\":\"Thomas D. Lockwood\",\"doi\":\"10.1007/s10534-024-00590-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Independent trials indicate that either oral Zn<sup>2+</sup> or metformin can separately improve COVID-19 outcomes by approximately 40%. Coordination chemistry predicts a mechanistic relationship and therapeutic synergy. Zn<sup>2+</sup> deficit is a known risk factor for both COVID-19 and non-infectious inflammation. Most dietary Zn<sup>2+</sup> is not absorbed. Metformin is a naked ligand that presumably increases intestinal Zn<sup>2+</sup> bioavailability and active absorption by cation transporters known to transport metformin. Intracellular Zn<sup>2+</sup> provides a natural buffer of many protease reactions; the variable “set point” is determined by Zn<sup>2+</sup> regulation or availability. A Zn<sup>2+</sup>-interactive protease network is suggested here. The two viral cysteine proteases are therapeutic targets against COVID-19. Viral and many host proteases are submaximally inhibited by exchangeable cell Zn<sup>2+</sup>. Inhibition of cysteine proteases can improve COVID-19 outcomes and non-infectious inflammation. Metformin reportedly enhances the natural moderating effect of Zn<sup>2+</sup> on bioassayed proteome degradation. Firstly, the dissociable metformin–Zn<sup>2+</sup> complex could be actively transported by intestinal cation transporters; thereby creating artificial pathways of absorption and increased body Zn<sup>2+</sup> content. Secondly, metformin Zn<sup>2+</sup> coordination can create a non-natural protease inhibitor independent of cell Zn<sup>2+</sup> content. Moderation of peptidolytic reactions by either or both mechanisms could slow (a) viral multiplication (b) viral invasion and (c) the pathogenic host inflammatory response. These combined actions could allow development of acquired immunity to clear the infection before life-threatening inflammation. Nirmatrelvir (Paxlovid®) opposes COVID-19 by selective inhibition the viral main protease by a Zn<sup>2+</sup>-independent mechanism. Pending safety evaluation, predictable synergistic benefits of metformin and Zn<sup>2+</sup>, and perhaps metformin/Zn<sup>2+</sup>/Paxlovid® co-administration should be investigated.</p></div>\",\"PeriodicalId\":491,\"journal\":{\"name\":\"Biometals\",\"volume\":\"37 4\",\"pages\":\"983 - 1022\"},\"PeriodicalIF\":4.1000,\"publicationDate\":\"2024-04-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://link.springer.com/content/pdf/10.1007/s10534-024-00590-5.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biometals\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://link.springer.com/article/10.1007/s10534-024-00590-5\",\"RegionNum\":3,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biometals","FirstCategoryId":"99","ListUrlMain":"https://link.springer.com/article/10.1007/s10534-024-00590-5","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
Coordination chemistry suggests that independently observed benefits of metformin and Zn2+ against COVID-19 are not independent
Independent trials indicate that either oral Zn2+ or metformin can separately improve COVID-19 outcomes by approximately 40%. Coordination chemistry predicts a mechanistic relationship and therapeutic synergy. Zn2+ deficit is a known risk factor for both COVID-19 and non-infectious inflammation. Most dietary Zn2+ is not absorbed. Metformin is a naked ligand that presumably increases intestinal Zn2+ bioavailability and active absorption by cation transporters known to transport metformin. Intracellular Zn2+ provides a natural buffer of many protease reactions; the variable “set point” is determined by Zn2+ regulation or availability. A Zn2+-interactive protease network is suggested here. The two viral cysteine proteases are therapeutic targets against COVID-19. Viral and many host proteases are submaximally inhibited by exchangeable cell Zn2+. Inhibition of cysteine proteases can improve COVID-19 outcomes and non-infectious inflammation. Metformin reportedly enhances the natural moderating effect of Zn2+ on bioassayed proteome degradation. Firstly, the dissociable metformin–Zn2+ complex could be actively transported by intestinal cation transporters; thereby creating artificial pathways of absorption and increased body Zn2+ content. Secondly, metformin Zn2+ coordination can create a non-natural protease inhibitor independent of cell Zn2+ content. Moderation of peptidolytic reactions by either or both mechanisms could slow (a) viral multiplication (b) viral invasion and (c) the pathogenic host inflammatory response. These combined actions could allow development of acquired immunity to clear the infection before life-threatening inflammation. Nirmatrelvir (Paxlovid®) opposes COVID-19 by selective inhibition the viral main protease by a Zn2+-independent mechanism. Pending safety evaluation, predictable synergistic benefits of metformin and Zn2+, and perhaps metformin/Zn2+/Paxlovid® co-administration should be investigated.
期刊介绍:
BioMetals is the only established journal to feature the important role of metal ions in chemistry, biology, biochemistry, environmental science, and medicine. BioMetals is an international, multidisciplinary journal singularly devoted to the rapid publication of the fundamental advances of both basic and applied research in this field. BioMetals offers a forum for innovative research and clinical results on the structure and function of:
- metal ions
- metal chelates,
- siderophores,
- metal-containing proteins
- biominerals in all biosystems.
- BioMetals rapidly publishes original articles and reviews.
BioMetals is a journal for metals researchers who practice in medicine, biochemistry, pharmacology, toxicology, microbiology, cell biology, chemistry, and plant physiology who are based academic, industrial and government laboratories.